Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fariba Karamloo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Allergy|May 14, 2020
SARS-CoV-2 immunogenicity at the crossroadsFariba Karamloo, Renate König
The Journal of Experimental Medicine|June 3, 2004
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cellsMübeccel Akdis, Johan Verhagen, Alison Taylor, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapyFatimah Kussebi, Fariba Karamloo, Claudio Rhyner, et al.
European Journal of Immunology|October 6, 2005
Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopesFariba Karamloo, Peter Schmid-Grendelmeier, Fatimah Kussebi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Allergy|May 14, 2020
SARS-CoV-2 immunogenicity at the crossroadsFariba Karamloo, Renate König
The Journal of Experimental Medicine|June 3, 2004
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cellsMübeccel Akdis, Johan Verhagen, Alison Taylor, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapyFatimah Kussebi, Fariba Karamloo, Claudio Rhyner, et al.
European Journal of Immunology|October 6, 2005
Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopesFariba Karamloo, Peter Schmid-Grendelmeier, Fatimah Kussebi, et al.
Pageof 1